Clorox (CLX) Valuation Revisited After Removal From Major Global Index

Index removal puts fresh focus on Clorox shares

Clorox (CLX) has been removed from the FTSE All-World Index (USD), an index-level change that can prompt portfolio rebalancing by benchmarked funds and encourage investors to reassess how the stock fits within their broader allocations.

See our latest analysis for Clorox.

At a latest share price of $102.04, Clorox has a 30 day share price return of a 19.17% decline, alongside a 1 year total shareholder return of a 27.38% loss, indicating pressure on long term momentum despite a modestly positive 90 day move.

If this kind of index related volatility has you thinking about diversification, it could be a useful moment to broaden your search using the 20 top founder-led companies

With Clorox trading at $102.04 and flagged with both a value score of 6 and a 55% intrinsic discount, the key question is whether markets are overlooking a potential reset or already accounting for any future growth.

Most Popular Narrative: 14.8% Undervalued

Against a last close of $102.04, the most followed narrative pegs Clorox’s fair value at $119.76, framing today’s price as a discount to long run cash flows.

The full-scale implementation of a modern ERP system is expected to drive long-term operational efficiencies, improving supply chain visibility, speeding innovation cycles, and reducing structural costs. This is expected to support margin expansion and sustained earnings growth once short-term transition noise normalizes.

Read the complete narrative.

Want to see what sits under that ERP comment and earnings outlook? The narrative leans on specific revenue paths, margin rebuilding, and a future earnings multiple that ties everything together.

Result: Fair Value of $119.76 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, muted category growth and intense price competition in areas like Glad and cat litter could keep pressure on volumes and margins, which may challenge that reset narrative.

Find out about the key risks to this Clorox narrative.

Next Steps

With sentiment clearly split between those focused on risks and those watching potential rewards, move quickly to review the full picture for yourself with 6 key rewards and 1 important warning sign

Ready to uncover your next investing idea?

If Clorox’s story has sharpened your thinking, do not stop here, use the Simply Wall St Screener to spot other opportunities before they move without you.

• Target stability first by checking companies that appear resilient through the 67 resilient stocks with low risk scores
• Hunt for value by scanning for businesses that look mispriced using the screener containing 26 high quality undiscovered gems
• Prioritise balance sheet strength by reviewing companies that show solid financial footing with the solid balance sheet and fundamentals stocks screener (39 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com